Journal of Korean Medicine for Obesity Research (한방비만학회지)

The Society of Korean Medicine for obesity Research (한방비만학회)
권호 표지

The Role of Gut Microbiota in Obesity and Utilization of Fermented Herbal Extracts

비만에서 장내 미생물 균총의 역할과 발효 한양의 활용

  • Park, Jung-Hyun (Department of Oriental Rehabilitation Medicine, Dongguk University Medical Center) ;
  • Kim, Ho-Jun (Department of Oriental Rehabilitation Medicine, Dongguk University Medical Center) ;
  • Lee, Myeong-Jong (Department of Oriental Rehabilitation Medicine, Dongguk University Medical Center)
  • 박정현 (동국대학교의료원 한방재활의학과) ;
  • 김호준 (동국대학교의료원 한방재활의학과) ;
  • 이명종 (동국대학교의료원 한방재활의학과)
  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Complex microbial communities play an important role in the human health and co-evolved with human in the form of symbiosis. Many literatures provide new evidences that the increased prevalence of obesity cannot be attributed solely to changes in the human genome, nutritional habits, or reduction of physical activity in our daily lives. The intestinal flora was recently proposed as an environmental factor responsible for the control of body weight and energy metabolism. A number of studies suggest that the modulation of gut microbiota affects host metabolism and has an impact on energy storage and demonstrated a role for the gut microbiota in weight gain, fat increase, and insulin resistance. Variations in microbiota composition are found in obese humans and mice and the microbiota from an obese mouse confers an obese phenotype when transferred to an axenic mouse. As well, the gut microbial flora plays a role in converting nutrients into calories. Specific strategies for modifying gut microbiota may be a useful means to treat or prevent obesity. Dietary modulations of gut microbiota with a view to increasing bifidobacteria have demonstrated to reduce endotoxemia and improve metabolic diseases such as obesity. The fermentation of medicinal herbs is intended to exert a favorable influence on digestability, bioavailability and pharmacological activity of herbal extract. Therefore we also expect that the fermented herbal extracts may open up a new area to treat obesity through modulating gut microbiota.

Keywords

References

  1. Hill JO, Peters JC. Environmental contributions to the obesity epidemic. Science. 1998;280:1371-4.
  2. D. Raoult. Obesity pandemics and the modification of digestive bacterial flora. Eur J Clin Microbiol Infect Dis. 2006;doi:10.1007/s10096-008-0490-x.
  3. Hill,JO. Understanding and addressing the epidemic of obesity: An energy balance perspective. Endocr. Rev. 2006;doi: 10.1210/er.2006-0032.
  4. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon Jl. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA. 2005;102: 11070-5.
  5. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. The gut microbiota as an environmental factor that regmates fat storage. Proc Natl Acad Sci USA. 2004;101:15718-23.
  6. Backhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA. 2007;104:979-84.
  7. Christina A. Tennyson and Gerald Friedman. Microecology, obesity, and probiotics. Curr Opin Endocrinol Diabetes Obes. 2008;15:422-7.
  8. 김희남. 유전체학시대의 장내 미생물 군집에 대한 새로운 기능적 발견. Biochemistry and Molecular Biology News. 2007;3:1-5.
  9. Whitman W, D Coleman, et al. Prokaryotes: the unseen majority. Proc Natl Acad Sci USA. 1998; 95:6578-83.
  10. Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355-9.
  11. Nicholson JK, Holmes E, Wilson ID. Gut microorganisms, mammalian metabolism and personalized healthcare. Nat Rev Microbiol. 2005;3:431-8.
  12. Pam BE, Elisabeth MB, Charles NB, et al. Diversity of the Human Intestinal Microbial Flora. Science. 2005;308(5728):1635-8.
  13. Farhadi A, Banan A, Fields J & Keshavarzian A et al. Intestinal barrier:an interface between health and disease. J of Gastroenterol Hepatol. 2003;18(5):479-97.
  14. Le Blay G, Blottiere HM, Ferrier L & Le Foll E et al. Short chan fatty acids induce cytoskeletal and extracellular protein modifications associated with modulation of proliferation on primary culture of rat intestinal smooth muscle cells. Dig Dis Sci. 2000.45: 1623-30.
  15. Marik PE. Iglesias J. Intestinal mucosal permeability: mechanism and implications for treatment. Crit Care. 1999;27(8): 1650-1.
  16. Sawada Y, Pereira SP, Murphy GM & Dowling RH et al. Polyamines in the intestinal lumen of patients with small bowel bacterial overgrowth. Biochem Soc Trans. 1994;22(4):392S.
  17. Lee WK, Lee SM, Bae HS, Baek YG. Effect of Bifidobacterium longum HY8001 Administration on human fecal bacterial enzymes and microflora. Kor J Appl Microbiol Biotechnol. 1999; 27(4):267-72.
  18. Finegold S. D. Molitoris, et al. Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis. 2002;35:S6-S16.
  19. Stebbings S, K Munro, et al. Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology. 2002;41:1395-401.
  20. Ott S, M Musfeldt, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflannnatory bowel disease. Gut. 2004;53:685-93.
  21. Lehtonen L, Kortekangas P, Oksman P, Eerola E, Aro H, Toivanen A. Synovial fluid muramic acid in acute inflannnatory arthritis. Br J Rheumatol. 1994: 13;1127-30.
  22. Slrinebaum R, Neumann VC, Cooke EM, Wright V. Comparison of faecal florae in patients with rheumatoid arthritis and controls. Br J Rheumatol. 1987;26:329-33.
  23. Peltonen R, Nenonen M, Helve T, Hanninen 0, Toivanen P, Eerola E. Faecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet. Br J Rheumatol. 1997;36(1):64-8.
  24. Hollander D, Vadheim CM, Brettholz E & Petersen GM et al. Increased intestinal permeability in patients with Crohn's disease and their relatives. Ann. Intern. Med. 1986:105;883-5.
  25. Deitch EA, Berg R, Specian R. Endotoxin promotes the translocation of bacteria from the gut. Arch Surg. 1987;122:185-90.
  26. Caridis DT, Reinhold RB, Woodruff PWH, Fine J. Endotoxaemia in man. Lancet. 1972;2:1381-6.
  27. Ramachandran A, Balasubramanian KA. Intestinal dysfunction in liver cirrhosis: its role in spontaneous bacterial peritonitis. J Gastroenterol Hepatol. 2001;16:607-12.
  28. Parlesak A, Schafer C, Schutz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol. 2000;32:742-7.
  29. Basu S & Eriksson M.Oxidative injury and snrvival during endotoxemia. FEBS Lett. 1998.6;438 (3): 159-60.
  30. Jokelainen, Reinke & Nanji. Nf-kappa B activationis associated with free radical generationand endotoxemia and precedes pathological liver injury in experimental alcoholic liver disease. Cytokine. 2001;16(1):36-9.
  31. Sanchez-Rodriguez A, Criado M, Rodriguez-Lopez AM & Esteller A et al. Increased nitric oxide synthesis and inducible nitric oxide synthase expression in patients with alcoholic and non-alcoholic liber cirrhosis. Clin Sci. 1998;94(6):637-43.
  32. Hichey MJ, Sihota E, Amrani A & Santamaria P et al. Inducible nitric oxide synthase in endotoxemia: chimeric mice reveal different cellular sources in various tissues. FASEB J. 2002;16(9):1141-3.
  33. Schaffler A, Moller-Ladner U, Scholmerich J, Buchler C. Role of Adipose Tissue as an Inflammatory Organ in Human Diseases. Endocr Rev. 2006;276(5):449-67.
  34. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111-9.
  35. Neal MD, Leaphart C, Levy R, Prince J, Billiar TR, Watkins S, Li J, Cetin S, Ford H, Schreiber A, Hackam DJ: Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol. 2006; 176:3070-9.
  36. Vreugdenhil AC, Rousseau CH, Hartung T, Greve JW, van "t Veer C, Brnnman WA lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J Immunol. 2003; 170: 1399-405.
  37. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990; 249:1431-3.
  38. Brugman S, Klatter FA, Visser JT, WildeboerVeloo AC, Harmsen HJ, Rozing J, Bos NA: Antibiotic treatment partially protects against type 1 diabetes in the bio-breeding diabetes-prone rat: is the gut flora involved in the development of type 1 diabetes? Diabetologia. 2006;49:2105-8.
  39. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761-72.
  40. Cani PD, Bibiloni R, Knauf C, et al. Changes in gut mierobiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;doi: 10.2337/db07-1403.
  41. Creely SJ, McTernan PG, Kusminski CM, et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab. 2007;292:E740-E747.
  42. Seo HY, Jeon WK., Kang JH, et al. The Effect of Preoperative Oral Application of Bovine Colostrum on Endotoxemia and $TNF-{\alpha}$ in Abdominal Surgery. J Korean surgical society. 2006;70(6): 462-9.
  43. Ley RE, Turnbaugh PJ, Klein S. & Gordon JI.Microbial ecology: Human gut microbes associated with obesity. Nature. 2006;444:1022-3.
  44. Turnbaugh PJ, Ley RE, Mahowald M, Magrini V, Mardis ER. and Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-31.
  45. Matej Bajzer, Randy JS. Obesity and gut flora. Nature. 2006;444: 1009-10.
  46. Patrice D. Cani and Nathalie M. Delzenn. Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care. 2007;10:729-34.
  47. Palmer C, Bik EM, Digiulio DB, et al. Development of the human infant intestinal microbiota. PLoS BioI. 2007; 5:e177.
  48. Lindberg E, Adlerberth I, Hesselmar B, et al. High rate of transfer of Staphylococcus aureus from parental skin to infant gut flora. J Clin Microbiol. 2004;42:530-4.
  49. Lundell A-C, Adlerberth I, Lindberg E, et al. Increased levels of circulating soluble CD 14 but not CD83 in infants are associated with early intestinal colonization with Staphylococcus aureus. Clin Exp Allergy. 2007;37:62-71.
  50. Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut microflora improves high-fat diet-induced diabetes through a mechanism associated with endotoxemia. Diabetologia. 2007;50(11):2374-83.
  51. Daubioul CA, Horsmans Y, Lambert P, et al. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur J Clin Nutr. 2005;59:723-6.
  52. Lee K, Paek K, Lee HY, Park JR, Lee Y. Antiobesity effect of trans-10,cis-12-conjugated linoleic acid-producing Lactobacillus plantarum PL62 on diet-induced obese mice. J Appl MicrobioI. 2007;103(4):1140-6.
  53. Agerholm-Larsen L, Raben A, Haulrik N, et al. Effect of 8week intake of probiotic milk products on risk factors for cardiovascular disease. Eur J Clin Nutr. 2000;54:288-97.
  54. Ali AA, Belasquez MT, Hansen CT, Mohamed AI, Bhathena SJ. Effects of soybean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. J Nutr Bioch. 2004;15: 583-90.
  55. Jung YJ, Han DO, Choi BH, et al. Effect of Fermented Herbal Extracts, HP-1 on Enzyme Activities and Gene Expressions Related to Alcohol Metabolism in Ethanol-loaded Rats. Korean J. Oriental Physiology & Pathology. 2007;21(2): 387-91.
  56. Choi JH, Kim HM, Song YS, et al. Anti-aging Effects Saccharomyces Fermented Modified Kyungohkgo Extract on Skin. Kor J. herbology. 2007; 22(4):227-32.
  57. Han HS, Park WS, Lee YJ Studies on the lmmuno Modulating Acitivity of Fermented Artemisiae Argyi Folium Extract. Kor J. herbology. 2008;23(3): 103-12.
  58. Lee SN, Scm JB, Scm JH, et al. Effects of Herbal Composition and Fermented Cervi Pantotrichum Cornu on Longitudinal Bone Growth in Adolescent Male Rats.Kor J. herbology. 2009;24(1): 121-31.
  59. Kong BM, Min JW, Kim SY, et al. Physico-Chemical Characteristics of White, Fermented and Red Ginseng Extracts. Kor J. Ginseng. 2008; 32(3):238-43.
  60. Patrick L, Uzick M. Cardiovascular disease; C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase, Red yeast rice and olive oil polyphenols. Altern Med Rev.2001;6(3): 248-71.
  61. Kang MR, Kim JY, HYun YJ, et al. The effect of Red-Yeast -Rice supplement on serum lipid profile and glucose control in subjects with impaired fasting glucose or impaired glucose tolerance. Kor J. Nutr. 2008;41(1):31-40.
  62. Berg RD. Bacterial translocation from the gastrointestinal tract. Adv Exp Med BioI. 1999;473: 11-30.
  63. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine n critically ill patients?: a systematic review of the evidence. JAMA. 2001;286:944-53.
  64. Gotteland, M., Crochet, S. and Verbeke, S. Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indomethacin in humans. Aliment. Pharmacol. Ther. 2001; 15:11-7.
  65. Kanauchi, O., Mitsuyama, K., Araki, Y. and Andoh, A. Modification of intestinal flora in the treatment of inflammatory bowel disease. Curr. Pharm. Des. 2003;9:333-46.
  66. Daubioul CA, Horsmans Y, Lambert P, et al. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur J Clin Nutr 2005;59:723-6.
  67. 김동현, 이승원, 박주석, 장일성. 대장암모델 생쥐에 발효녹용의 발암 억제 효과. 경희약대논문집. 1995;23:93-5.
  68. 서영국. 어성초 즙 발효제품의 항산화 및 항알레르기 활성 .2005. 순천대학교.
  69. 김동현. 녹용발효와 생리활성. 생약학회지. 1994; 25(3):233-7.
  70. 이정운, 이영철, 김동현, 나혜숙, 마진열. 발효기볍 을 이용한 SD rat의 갱년기 비만 치료효과에 관한 연구. 한국임상약학회지. 2005;15(2): 118-26.
  71. 송희옥. 마황이 Zucker rats의 체중, 식욕, 혈액, 지방조직 및 지방대사 관련 유전자 변화에 미치는 영향.2006. 경희대학교.
  72. Sandra LC, Sharpless KE, Satterfield ME, Ihara T, Phinney KW, Yen JH, Wise SA, Gay ML, Lam JW, McCooeye M, Gardner G, Fraser C, Sturgeon R, Roman M. Determination of ephedrine alkaloids in dietary suppelement standard reference materials. Anal Chem. 2005;77(10): 101-12.
  73. Shin Yl, The effects of fermented Mahuang on obese rats fed by high fat diet. 2009. Graduated school of Dong-guk University.